Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Omalizumab treatment in Samter's triad: case series and review of the literature.

Cameli P, Perruzza M, Salvini M, Fui A, Cekorja B, Refini RM, Sestini P, Bargagli E.

Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8124-8129. doi: 10.26355/eurrev_201909_19031.

2.

The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases.

Bargagli E, Cameli P, Carleo A, Refini RM, Bergantini L, D'alessandro M, Vietri L, Perillo F, Volterrani L, Rottoli P, Bini L, Landi C.

Panminerva Med. 2019 Sep 24. doi: 10.23736/S0031-0808.19.03754-6. [Epub ahead of print]

PMID:
31577091
3.

NK and NKT-like cells in granulomatous and fibrotic lung diseases.

Bergantini L, Cameli P, d'Alessandro M, Vagaggini C, Refini RM, Landi C, Pieroni MG, Spalletti M, Sestini P, Bargagli E.

Clin Exp Med. 2019 Nov;19(4):487-494. doi: 10.1007/s10238-019-00578-3. Epub 2019 Sep 4.

PMID:
31485847
4.

New concepts in the pathogenesis of sarcoidosis.

Bennett D, Bargagli E, Refini RM, Rottoli P.

Expert Rev Respir Med. 2019 Oct;13(10):981-991. doi: 10.1080/17476348.2019.1655401. Epub 2019 Aug 23.

PMID:
31414923
5.

Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis.

Cameli P, Bergantini L, Salvini M, Refini RM, Pieroni M, Bargagli E, Sestini P.

Nitric Oxide. 2019 Aug 1;89:41-45. doi: 10.1016/j.niox.2019.05.001. Epub 2019 May 2.

PMID:
31054949
6.

Pirfenidone Therapy for Familial Pulmonary Fibrosis: A Real-Life Study.

Bennett D, Refini RM, Valentini ML, Fui A, Fossi A, Pieroni M, Mazzei MA, Rottoli P.

Lung. 2019 Apr;197(2):147-153. doi: 10.1007/s00408-019-00203-w. Epub 2019 Feb 13.

PMID:
30758708
7.

Diagnosis of idiopathic pulmonary fibrosis by virtual means using "IPFdatabase"- a new software.

Bennett D, Mazzei MA, Collins B, Bargagli E, Pipavath S, Spina D, Valentini ML, Rinaldi C, Bettini G, Ginori A, Refini RM, Rottoli P, Raghu G.

Respir Med. 2019 Feb;147:31-36. doi: 10.1016/j.rmed.2018.12.011. Epub 2019 Jan 3.

PMID:
30704696
8.

Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.

Cameli P, Bargagli E, Bergantini L, Refini RM, Pieroni M, Sestini P, Rottoli P.

J Breath Res. 2019 Mar 27;13(2):026008. doi: 10.1088/1752-7163/ab0233.

PMID:
30690441
9.

Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.

Bennett D, Salvini M, Fui A, Cillis G, Cameli P, Mazzei MA, Fossi A, Refini RM, Rottoli P.

Inflammation. 2019 Apr;42(2):463-470. doi: 10.1007/s10753-018-00955-2.

PMID:
30680696
10.

The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.

Harari S, Caminati A, Confalonieri M, Poletti V, Vancheri C, Pesci A, Rogliani P, Luppi F, Agostini C, Rottoli P, Sanduzzi Zamparelli A, Sebastiani A, Della Porta R, Salton F, Messore B, Tomassetti S, Rosso R, Biffi A, Puxeddu E, Cerri S, Cinetto F, Refini RM, Bocchino M, Di Michele L, Specchia C, Albera C; ILDINET (Interstitial Lung Diseases Italian Network).

Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999.

PMID:
30675755
11.

Postoperative acute kidney injury in lung transplant recipients.

Bennett D, Fossi A, Marchetti L, Lanzarone N, Sisi S, Refini RM, Sestini P, Luzzi L, Paladini P, Rottoli P.

Interact Cardiovasc Thorac Surg. 2019 Jun 1;28(6):929-935. doi: 10.1093/icvts/ivy355.

PMID:
30649317
12.

Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome.

Bennett D, Fossi A, Chiarello G, Refini RM, Luzzi L, Paladini P, Materozzi M, Figura N, Nuti R, Rottoli P.

Lung. 2019 Feb;197(1):95-99. doi: 10.1007/s00408-018-0178-7. Epub 2018 Nov 19.

PMID:
30456701
13.

Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers.

Landi C, Bargagli E, Carleo A, Refini RM, Bennett D, Bianchi L, Cillis G, Prasse A, Bini L, Rottoli P.

Rheumatology (Oxford). 2019 Jan 1;58(1):165-178. doi: 10.1093/rheumatology/key223.

PMID:
30239835
14.

Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns.

Bennett D, Mazzei MA, Squitieri NC, Bargagli E, Refini RM, Fossi A, Volterrani L, Rottoli P.

Respir Med. 2017 May;126:75-83. doi: 10.1016/j.rmed.2017.03.020. Epub 2017 Mar 22.

15.

Posttransplant solid organ malignancies in lung transplant recipients: a single-center experience and review of the literature.

Bennett D, Fossi A, Refini RM, Gentili F, Luzzi L, Voltolini L, Paladini P, Mazzei MA, Rottoli P.

Tumori. 2016 Dec 1;102(6):574-581. doi: 10.5301/tj.5000557. Epub 2016 Aug 23. Review.

PMID:
27647228
16.

Idiopathic pulmonary fibrosis a rare disease with severe bone fragility.

Caffarelli C, Gonnelli S, Tomai Pitinca MD, Francolini V, Fui A, Bargagli E, Refini RM, Bennett D, Nuti R, Rottoli P.

Intern Emerg Med. 2016 Dec;11(8):1087-1094. Epub 2016 Jul 8.

PMID:
27393142
17.

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.

Vitulo P, Stanziola A, Confalonieri M, Libertucci D, Oggionni T, Rottoli P, Paciocco G, Tuzzolino F, Martino L, Beretta M, Callari A, Amaducci A, Badagliacca R, Poscia R, Meloni F, Refini RM, Geri P, Baldi S, Ghio S, D'Alto M, Argiento P, Sofia M, Guardamagna M, Pezzuto B, Vizza CD.

J Heart Lung Transplant. 2017 Feb;36(2):166-174. doi: 10.1016/j.healun.2016.04.010. Epub 2016 May 7.

PMID:
27329400
18.

A functional proteomics approach to the comprehension of sarcoidosis.

Landi C, Bargagli E, Carleo A, Bianchi L, Gagliardi A, Cillis G, Perari MG, Refini RM, Prasse A, Bini L, Rottoli P.

J Proteomics. 2015 Oct 14;128:375-87. doi: 10.1016/j.jprot.2015.08.012. Epub 2015 Sep 2.

PMID:
26342673
19.

Exhaled nitric oxide and carbon monoxide in lung transplanted patients.

Cameli P, Bargagli E, Fossi A, Bennett D, Voltolini L, Refini RM, Gotti G, Rottoli P.

Respir Med. 2015 Sep;109(9):1224-9. doi: 10.1016/j.rmed.2015.07.005. Epub 2015 Jul 9.

20.

Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience.

Bennett D, Fossi A, Bargagli E, Refini RM, Pieroni M, Luzzi L, Ghiribelli C, Paladini P, Voltolini L, Rottoli P.

Lung. 2015 Oct;193(5):677-81. doi: 10.1007/s00408-015-9767-x. Epub 2015 Jul 28.

PMID:
26216722
21.

Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent.

Bennett D, Bargagli E, Refini RM, Pieroni MG, Fossi A, Romeo R, Volterrani L, Mazzei MA, Rottoli P.

Int J Occup Med Environ Health. 2015;28(4):775-9. doi: 10.13075/ijomeh.1896.00462.

22.

Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model.

Ruocco G, Cekorja B, Rottoli P, Refini RM, Pellegrini M, Di Tommaso C, Del Castillo G, Franci B, Nuti R, Palazzuoli A.

Respir Med. 2015 Mar;109(3):406-15. doi: 10.1016/j.rmed.2014.12.011. Epub 2015 Jan 3.

23.

A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls.

Landi C, Bargagli E, Carleo A, Bianchi L, Gagliardi A, Prasse A, Perari MG, Refini RM, Bini L, Rottoli P.

Proteomics Clin Appl. 2014 Dec;8(11-12):932-50. doi: 10.1002/prca.201400001. Epub 2014 Oct 22.

PMID:
25169739
24.

Exhaled nitric oxide in interstitial lung diseases.

Cameli P, Bargagli E, Refini RM, Pieroni MG, Bennett D, Rottoli P.

Respir Physiol Neurobiol. 2014 Jun 15;197:46-52. doi: 10.1016/j.resp.2014.03.011. Epub 2014 Apr 2.

PMID:
24703971
25.

Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis.

Bennett D, Bargagli E, Refini RM, Campagna MS, Gennari L, Nuti R, Figura N, Rottoli P.

Eur Respir J. 2014 Feb;43(2):635-8. doi: 10.1183/09031936.00104813. Epub 2013 Oct 10. No abstract available.

26.

Serum analysis of coagulation factors in IPF and NSIP.

Bargagli E, Madioni C, Bianchi N, Refini RM, Cappelli R, Rottoli P.

Inflammation. 2014 Feb;37(1):10-6. doi: 10.1007/s10753-013-9706-z.

PMID:
23912648
27.

Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.

Castria D, Refini RM, Bargagli E, Mezzasalma F, Pierli C, Rottoli P.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):681-9.

PMID:
23058018
28.

Utility of spiral CAT scan in the follow-up of patients with pulmonary Langerhans cell histiocytosis.

Abbritti M, Mazzei MA, Bargagli E, Refini RM, Penza F, Perari MG, Volterrani L, Rottoli P.

Eur J Radiol. 2012 Aug;81(8):1907-12. doi: 10.1016/j.ejrad.2011.04.018. Epub 2011 May 6.

PMID:
21549535
29.

Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis?

Bargagli E, Olivieri C, Cintorino M, Refini RM, Bianchi N, Prasse A, Rottoli P.

Inflammation. 2011 Apr;34(2):85-91. doi: 10.1007/s10753-010-9210-7.

PMID:
20422274
30.

Exhaled carbon monoxide in sarcoidosis.

Ciarleglio G, Refini RM, Pieroni MG, Martino VA, Bargagli E, Rottoli P, Sestini P.

Sarcoidosis Vasc Diffuse Lung Dis. 2008 Sep;25(1):46-50.

PMID:
19070260
31.

Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis.

Bargagli E, Margollicci M, Perrone A, Luddi A, Perari MG, Bianchi N, Refini RM, Grosso S, Volterrani L, Rottoli P.

Sarcoidosis Vasc Diffuse Lung Dis. 2007 Mar;24(1):59-64.

PMID:
18069420
32.

Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses.

Sestini P, Refini RM, Pieroni MG, Vaghi A, Robuschi M, Bianco S.

Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1228-33.

PMID:
10194170
33.

Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions.

Sestini P, Refini RM, Pieroni MG, Vaghi A, Robuschi M, Bianco S.

J Allergy Clin Immunol. 1997 Jul;100(1):71-7.

PMID:
9257790
34.

Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium.

Robuschi M, Gambaro G, Sestini P, Pieroni MG, Refini RM, Vaghi A, Bianco S.

Am J Respir Crit Care Med. 1997 Apr;155(4):1461-4.

PMID:
9105094
35.

Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.

Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M.

Am J Respir Crit Care Med. 1996 Feb;153(2):572-5.

PMID:
8564100
36.

Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma.

Bianco S, Vaghi A, Robuschi M, Refini RM, Pieroni MG, Sestini P.

J Allergy Clin Immunol. 1995 May;95(5 Pt 1):937-43.

PMID:
7751513
37.

Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics.

Sestini P, Pieroni MG, Refini RM, Robuschi M, Gambaro G, Spagnotto S, Vaghi A, Bianco S.

Eur Respir J. 1994 Oct;7(10):1825-9.

38.

Could NSAIDs have a role as antiasthmatic agents?

Bianco S, Pieroni MG, Refini RM, Robuschi M, Vaghi A, Sestini P.

Drugs. 1994 Jul;48(1):9-15. Review. No abstract available.

PMID:
7525197
39.

Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate.

Bianco S, Vaghi A, Pieroni MG, Robuschi M, Refini RM, Berni F, Sestini P.

Allergy. 1993 Nov;48(8):570-5.

PMID:
8116856
40.

Inhaled loop diuretics as potential new anti-asthmatic drugs.

Bianco S, Pieroni MG, Refini RM, Robuschi M, Vaghi A, Sestini P.

Eur Respir J. 1993 Jan;6(1):130-4. Review.

PMID:
8425583
41.

Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin.

Bianco S, Robuschi M, Petrigni G, Scuri M, Pieroni MG, Refini RM, Vaghi A, Sestini PS.

Drugs. 1993;46 Suppl 1:115-20. Review.

PMID:
7506148
42.

Protective activity of inhaled nonsteroidal antiinflammatory drugs on bronchial responsiveness to ultrasonically nebulized water.

Bianco S, Vaghi A, Pieroni MG, Robuschi M, Refini RM, Sestini P.

J Allergy Clin Immunol. 1992 Nov;90(5):833-9. Erratum in: J Allergy Clin Immunol 1993 Apr;91(4):966.

PMID:
1430708
43.

Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions.

Bianco S, Pieroni MG, Refini RM, Rottoli L, Sestini P.

N Engl J Med. 1989 Oct 19;321(16):1069-73.

PMID:
2797066

Supplemental Content

Loading ...
Support Center